ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,421Medicare Part D Prescriptions Filled, Including Refills

Rank: 921 out of 6645

$681K Total Retail Price of All Prescriptions

Rank: 676 out of 6645

260 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 260 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

8% of this provider’s 260 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 9,001 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 273 252 1 4
OMEPRAZOLE 266 245 2 6
SIMVASTATIN 253 247 3 1
LOSARTAN POTASSIUM 171 168 4 12
FUROSEMIDE 167 162 5 11
ATENOLOL 161 153 6 8
TRAMADOL HCL 147 138 7 30
LOVAZA 142 141 8 68
ATORVASTATIN CALCIUM 142 126 8 10
AMLODIPINE BESYLATE 140 117 10 2
GABAPENTIN 135 132 11 18
METFORMIN HCL 134 115 12 7
METFORMIN HCL ER 126 114 13 89
PANTOPRAZOLE SODIUM 125 124 14 29
NEXIUM 123 118 15 40
VOLTAREN 121 121 16 108
BENAZEPRIL HCL 120 113 17 21
DONEPEZIL HCL 117 117 18 27
PLAVIX 113 113 19 49
ATELVIA 112 111 20 91
METOPROLOL SUCCINATE 111 101 21 24
ZOLPIDEM TARTRATE 108 101 22 17
CRESTOR 101 97 23 34
LISINOPRIL 101 101 23 3
BONIVA 99 99 25 191
ALLOPURINOL 97 85 26 31
AVODART 93 93 27 99
PRAVASTATIN SODIUM 91 79 28 20
JANUVIA 90 80 29 38
TAMSULOSIN HCL 88 88 30 22
ALENDRONATE SODIUM 87 86 31 14
BYSTOLIC 87 86 31 110
WARFARIN SODIUM 86 79 33 16
ROPINIROLE HCL 82 82 34 166
PROPRANOLOL HCL 79 66 35 151
GLIMEPIRIDE 78 65 36 47
NAMENDA 78 78 36 41
CELEBREX 77 77 38 54
CYMBALTA 77 68 38 78
TRAZODONE HCL 75 65 40 60
ADVAIR DISKUS 74 69 41 45
CLOPIDOGREL 69 68 42 36
FLUTICASONE PROPIONATE 69 69 42 26
ESCITALOPRAM OXALATE 68 65 44 86
CARVEDILOL 67 62 45 25
DIOVAN 65 65 46 19
SINGULAIR 61 60 47 76
ACTONEL 59 57 48 92
AZITHROMYCIN 59 54 48 44
EVISTA 57 44 50 90
DILTIAZEM 24HR ER 56 56 51 187
LEXAPRO 55 55 52 218
HYDROCODONE-ACETAMINOPHEN 55 49 S3 52 5
GLIPIZIDE XL 54 54 54 315
LIDODERM 54 54 54 53
DEXILANT 53 53 56 102
MELOXICAM 53 53 56 46
IBANDRONATE SODIUM 50 50 58 147
CITALOPRAM HBR 50 49 58 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 17, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.